BRADFORD SCHOLARS

    • Sign in
    View Item 
    •   Bradford Scholars
    • Health Studies
    • Health Studies Publications
    • View Item
    •   Bradford Scholars
    • Health Studies
    • Health Studies Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Bradford ScholarsCommunitiesAuthorsTitlesSubjectsPublication DateThis CollectionAuthorsTitlesSubjectsPublication Date

    My Account

    Sign in

    HELP

    Bradford Scholars FAQsCopyright Fact SheetPolicies Fact SheetDeposit Terms and ConditionsDigital Preservation Policy

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Designer benzodiazepines gidazepam and desalkygidazepam (bromonordiazepam): What do we know?

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Publication date
    2023
    End of Embargo
    2024-01-25
    Author
    Maskell, P.D.
    Wilson, G.
    Manchester, Kieran R.
    Keyword
    Designer benzodiazepines
    New psychoactive substances (NPS)
    Gidazepam
    Desalkygidazepam
    Bromonordiazepam
    Rights
    © The Author(s) 2023. Published by Oxford University Press. All rights reserved.
    Peer-Reviewed
    Yes
    Open Access status
    embargoedAccess
    
    Metadata
    Show full item record
    Abstract
    Designer benzodiazepines are one of the primary new psychoactive substances (NPS) threats around the world, being found in large numbers in post-mortem, driving under the influence of drugs (DUID) and drug facilitated sexual assault (DFSA) cases. Even though when compared to many other NPS types, such as opioids and cathinones, there are relatively few designer benzodiazepines being monitored. Recently a new NPS benzodiazepine has been reported in Europe, the USA and Canada, desalkygidazepam, also known as bromonordiazepam. This substance is a metabolite of the pro-drug gidazepam, a drug licenced for use in Ukraine and Russia under the name Gidazepam IC®. In the paper we review what is currently known about the use, pharmacology and analytical detection of gidazepam, its metabolite desalkygidazepam, and their other possible metabolites.
    URI
    http://hdl.handle.net/10454/19320
    Version
    Accepted manuscript
    Citation
    Maskell PD, Wilson G and Manchester KR (2023) Designer benzodiazepines gidazepam and desalkygidazepam (bromonordiazepam): What do we know? Journal of Analytical Toxicology. Accepted for Publication.
    Link to publisher’s version
    https://doi.org/10.1093/jat/bkad004
    Type
    Article
    Notes
    The full-text of this article will be released for public view at the end of the publisher embargo on 25 Jan 2024.
    Collections
    Health Studies Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.